POS-390 TOWARDS IDENTIFYING NEW TARGETS, LONG NON-CODING RNA (LNCRNA), IN DIABETIC KIDNEY DISEASE (DKD) - A NOVEL LNCRNA GM10603, A COMMON PATHOGENIC LNCRNA TO DKD?
Main Authors: | S. Redzepagic, C. Pollock |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024921005544 |
Similar Items
-
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk
by: Sabrina Scilletta, et al.
Published: (2023-04-01) -
Co-differential genes between DKD and aging: implications for a diagnostic model of DKD
by: Hongxuan Du, et al.
Published: (2024-02-01) -
Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone
by: Nicholas Chiu, et al.
Published: (2022-04-01) -
Detection of DKD stage 1 and treatment are essential
by: Narisa Futrakul, et al.
Published: (2018-10-01) -
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
by: John M. Flack, et al.
Published: (2023-12-01)